Holen Sie sich die Stockscreener-App
559.37
1.14%
6.30
Handel nachbörslich:
559.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
11 Best Medical Technology Stocks to Buy Right Now - Insider Monkey
IDEXX Laboratories stock (US45168D1046): strong Q1 earnings keep diagnostics specialist in focus - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock (US45168D1046): institutional selldown and animal health growth story - AD HOC NEWS
Insider sale notice: IDEXX Labs (NASDAQ: IDXX) files Form 144 - Stock Titan
HARVEY INVESTMENT CO LLC's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
Should IDEXX’s (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors? - Yahoo Finance
IDEXX announces UK availability of cancer Dx panel for early detection of canine lymphoma - MSN
IDEXX Laboratories stock (US45168D1046): Q1 2026 earnings beat, guidance hike and new kidney test in - AD HOC NEWS
IDEXX Laboratories stock (US45168D1046): Q1 2026 earnings beat and updated guidance keep veterinary - AD HOC NEWS
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles - Business Wire
IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate - Sahm
IDEXX Laboratories Inc (IDXX) Stock Up 3.2% and Still Undervalued -- GF Score: 99/100 - GuruFocus
IDEXX Laboratories stock (US45168D1046): fresh Q1 2026 earnings and guidance put diagnostics special - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 34% Potential Upside for Investors - DirectorsTalk Interviews
Elyxium Wealth LLC Invests $3.67 Billion in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Idexx Laboratories Shareholders Approve Governance and Meeting Reforms - The Globe and Mail
IDEXX Laboratories stock (US45167R1041): Diagnostics demand keeps investors focused - AD HOC NEWS
IDXX Technical Analysis & Stock Price Forecast - Intellectia AI
Northwestern Mutual Wealth Management Co. Increases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories stock (US45168D1046): Q1 2025 earnings highlight growth in pet diagnostics - AD HOC NEWS
IDEXX (NASDAQ: IDXX) declassifies board, grants 25% special-meeting right - Stock Titan
Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771 - Benzinga
Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $77 - Benzinga
In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Valu - Benzinga
Karen Peacock At IDEXX Laboratories Exercises Options Worth $0 - Benzinga
Engaging In Insider Activity, Sam Samad At IDEXX Laboratories Exercises Options Worth $0 - Benzinga
Bessemer Group Inc. Trims Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
AustralianSuper Pty Ltd Grows Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day - 01net
IDEXX (IDXX) director Vandebroek receives RSU and option grants as compensation - Stock Titan
Director Sam Samad (NASDAQ: IDXX) receives new stock units and options grant - Stock Titan
IDEXX (IDXX) director granted stock options and deferred stock units - Stock Titan
IDEXX (IDXX) director Lawrence Kingsley awarded RSUs and stock options - Stock Titan
IDEXX (IDXX) grants director RSUs and stock options at $533.92 - Stock Titan
IDEXX (NASDAQ: IDXX) director Hooley granted deferred units and options - Stock Titan
IDEXX (IDXX) director Stuart Essig granted RSUs and options in new equity awards - Stock Titan
IDEXX (NASDAQ: IDXX) director Bruce Claflin granted deferred stock units and options - Stock Titan
IDEXX (IDXX) director receives new stock options and deferred units - Stock Titan
Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)? - Insider Monkey
IDEXX Laboratories stock (US45167R1041): Q1 earnings beat with 14.3% revenue growth - AD HOC NEWS
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $714.36, Implies 35% Upside - TradingView
VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
TCW Concentrated Large Cap Growth Fund's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $721.5, Implies 35% Upside - TradingView
IDEXX Laboratories Inc (IDXX) Stock Down 4.7% -- Now Undervalued? GF Score: 98/100 - GuruFocus
IDEXX Laboratories stock (US45167R1041): Shares fall 5% despite beating earnings estimates - AD HOC NEWS
NewEdge Wealth LLC Acquires 3,629 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Shares Fall 5.0% -- What GF Score of 99 Tells Investors - GuruFocus
IDEXX Laboratories Drops 5.8% Amid Sector-Wide Selling - AlphaStreet
IDEXX (IDXX) director’s RSUs vest into 257 shares, holdings updated - Stock Titan
IDEXX (IDXX) director Szostak adds 257 shares as RSUs vest into stock - Stock Titan
IDEXX (IDXX) director Karen Peacock converts 101 RSUs into 102-share holding - Stock Titan
Director at IDEXX Laboratories (IDXX) gains 339 shares from RSU vesting - Stock Titan
IDEXX Laboratories (NASDAQ: IDXX) director gains 257 shares from RSU vesting - Stock Titan
Director Hooley of IDEXX (NASDAQ: IDXX) gains 158 common shares via RSU vesting - Stock Titan
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
BofA Sees Slower InVue Installations as Headwind for IDEXX Laboratories, Inc. (IDXX) - Insider Monkey
0.40%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):